Product References
CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities.
Nature
Han K,Pierce SE,Li A,Spees K,Anderson GR,Seoane JA,Lo YH,Dubreuil M,Olivas M,Kamber RA,Wainberg M,Kostyrko K,Kelly MR,Yousefi M,Simpkins SW,Yao D,Lee K,Kuo CJ,Jackson PK,Sweet-Cordero A,Kundaje A,Gentles AJ,Curtis C,Winslow MM,Bassik MC
AHR0321 was used in Immunocytochemistry-Immunofluorescence to reveal key differences between 2D and 3D cancer models, and establish a generalizable strategy for performing CRISPR screens in spheroids to reveal cancer vulnerabilities.
Wed Apr 01 00:00:00 EDT 2020
CRISPR screens in cancer spheroids identify 3D growth-specific vulnerabilities.
Nature
Han K,Pierce SE,Li A,Spees K,Anderson GR,Seoane JA,Lo YH,Dubreuil M,Olivas M,Kamber RA,Wainberg M,Kostyrko K,Kelly MR,Yousefi M,Simpkins SW,Yao D,Lee K,Kuo CJ,Jackson PK,Sweet-Cordero A,Kundaje A,Gentles AJ,Curtis C,Winslow MM,Bassik MC
AHR0321 was used in Immunocytochemistry-Immunofluorescence to reveal key differences between 2D and 3D cancer models, and establish a generalizable strategy for performing CRISPR screens in spheroids to reveal cancer vulnerabilities.
Wed Apr 01 00:00:00 EDT 2020
Targeting the insulin growth factor-1 receptor with fluorescent antibodies enables high resolution imaging of human pancreatic cancer in orthotopic mouse models.
Oncotarget
Park JY,Lee JY,Zhang Y,Hoffman RM,Bouvet M
AHR0321 was used in immunocytochemistry and immunohistochemistry - frozen section to test if fluorescently labeled insulin-like growth factor-1 receptor antibodies can be used to visualize pancreatic cancer in orthotopic nude mouse models
Tue Apr 05 00:00:00 EDT 2016
Fluorescent-Antibody Targeting of Insulin-Like Growth Factor-1 Receptor Visualizes Metastatic Human Colon Cancer in Orthotopic Mouse Models.
PloS one
Park JY,Murakami T,Lee JY,Zhang Y,Hoffman RM,Bouvet M
AHR0321 was used in immunocytochemistry to test if insulin-like growth factor-1 receptor antibodies enable the visualization of metastatic colon cancer in orthotopic nude mouse models
Thu Jun 30 00:00:00 EDT 2016
Metabolic syndrome and colorectal cancer: is hyperinsulinemia/insulin receptor-mediated angiogenesis a critical process?
Journal of geriatric oncology
Liu JJ,Druta M,Shibata D,Coppola D,Boler I,Elahi A,Reich RR,Siegel E,Extermann M
AHR0321 was used in immunohistochemistry - paraffin section to discuss mechanisms that link metabolic syndrome to colorectal cancer risk
Wed Jan 01 00:00:00 EST 2014
Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes.
PloS one
Mountzios G,Aivazi D,Kostopoulos I,Kourea HP,Kouvatseas G,Timotheadou E,Zebekakis P,Efstratiou I,Gogas H,Vamvouka C,Chrisafi S,Stofas A,Pentheroudakis G,Koutras A,Galani E,Bafaloukos D,Fountzilas G
AHR0321 was used in Immunohistochemistry to determine the level of protein expression of the critical components of the insulin-like growth factor receptor pathway and evaluate their prognostic significance across the different early breast cancer subtypes.
Tue Jan 06 00:00:00 EST 2015
Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas.
British journal of cancer
Gallardo A,Lerma E,Escuin D,Tibau A,Muñoz J,Ojeda B,Barnadas A,Adrover E,Sánchez-Tejada L,Giner D,Ortiz-Martínez F,Peiró G
AHR0321 was used in immunohistochemistry - paraffin section to investigate the contribution of the PI3K/Akt pathway to trastuzumab resistance
Tue Apr 10 00:00:00 EDT 2012
An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
Acta oncologica (Stockholm, Sweden)
Henriksen KL,Rasmussen BB,Lykkesfeldt AE,Møller S,Ejlertsen B,Mouridsen HT
AHR0321 was used in Immunohistochemistry to evaluate the association between response at recurrence to letrozole versus tamoxifen and the expression of oestrogen regulated proteins.
Tue May 12 00:00:00 EDT 2009
The pT1a and pT1b category subdivision in renal cell carcinoma: is it reflected by differences in tumour biology?
BJU international
Langner C,Ratschek M,Rehak P,Tsybrovskyy O,Zigeuner R
AHR0321 was used in immunohistochemistry - paraffin section to study the category subdivision of pT1a and pT1b in renal cell carcinoma
Tue Feb 01 00:00:00 EST 2005